558 related articles for article (PubMed ID: 26354831)
21. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
22. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
[TBL] [Abstract][Full Text] [Related]
23. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S.
De Stefano V; Simioni P; Rossi E; Tormene D; Za T; Pagnan A; Leone G
Haematologica; 2006 May; 91(5):695-8. PubMed ID: 16670075
[TBL] [Abstract][Full Text] [Related]
24. Venous thromboembolism in neonates and children.
Kenet G; Nowak-Göttl U
Best Pract Res Clin Haematol; 2012 Sep; 25(3):333-44. PubMed ID: 22959549
[TBL] [Abstract][Full Text] [Related]
25. In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband.
Rossi E; Ciminello A; Za T; Betti S; Leone G; De Stefano V
Thromb Haemost; 2011 Oct; 106(4):646-54. PubMed ID: 21833444
[TBL] [Abstract][Full Text] [Related]
26. The molecular mechanisms of inherited thrombophilia.
März W; Nauck M; Wieland H
Z Kardiol; 2000 Jul; 89(7):575-86. PubMed ID: 10957782
[TBL] [Abstract][Full Text] [Related]
27. Gender-specific and menstrual cycle dependent differences in circulating microparticles.
Toth B; Nikolajek K; Rank A; Nieuwland R; Lohse P; Pihusch V; Friese K; Thaler CJ
Platelets; 2007 Nov; 18(7):515-21. PubMed ID: 17957567
[TBL] [Abstract][Full Text] [Related]
28. VTE recurrence in patients with inherited deficiencies of natural anticoagulants.
Dentali F; Gianni M
Thromb Haemost; 2009 Jan; 101(1):5-6. PubMed ID: 19132180
[No Abstract] [Full Text] [Related]
29. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.
Baglin T; Luddington R; Brown K; Baglin C
Lancet; 2003 Aug; 362(9383):523-6. PubMed ID: 12932383
[TBL] [Abstract][Full Text] [Related]
30. Venous thromboembolism in Asia--an unrecognised and under-treated problem?
Angchaisuksiri P
Thromb Haemost; 2011 Oct; 106(4):585-90. PubMed ID: 21833449
[TBL] [Abstract][Full Text] [Related]
31. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
32. Prediction of ischemic stroke in young Indians: is thrombophilia profiling a way out?
Chatterjee T; Gupta N; Choudhry VP; Behari M; Saxena R; Ashraf MZ
Blood Coagul Fibrinolysis; 2013 Jun; 24(4):449-53. PubMed ID: 23337710
[TBL] [Abstract][Full Text] [Related]
33. Circulating microparticles and risk of venous thromboembolism.
Bucciarelli P; Martinelli I; Artoni A; Passamonti SM; Previtali E; Merati G; Tripodi A; Mannucci PM
Thromb Res; 2012 May; 129(5):591-7. PubMed ID: 21908018
[TBL] [Abstract][Full Text] [Related]
34. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
35. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
36. Thrombophilia as a multigenic disease.
Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
[TBL] [Abstract][Full Text] [Related]
37. Deficiencies of natural anticoagulants, protein C, protein S, and antithrombin.
Lipe B; Ornstein DL
Circulation; 2011 Oct; 124(14):e365-8. PubMed ID: 21969320
[No Abstract] [Full Text] [Related]
38. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
[TBL] [Abstract][Full Text] [Related]
39. Deficiencies of proteins C, S and antithrombin and factor V Leiden and the risk of ischemic strokes.
Soare AM; Popa C
J Med Life; 2010; 3(3):235-8. PubMed ID: 20945813
[TBL] [Abstract][Full Text] [Related]
40. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
